Viemed Healthcare
VMD
88 hedge funds and large institutions have $218M invested in Viemed Healthcare in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 9 closing their positions.
2,700% more call options, than puts
Call options by funds: $280K | Put options by funds: $10K
118% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 17
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
44% more capital invested
Capital invested by funds: $151M → $218M (+$66.4M)
9% more funds holding
Funds holding: 81 → 88 (+7)
4.79% more ownership
Funds ownership: 53.8% → 58.6% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
Top Sellers
VMD Hedge Fund Activity: Q1 2023 in Review
88 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q1 2023, worth a combined $218M — up 44% from $151M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new VMD positions and 9 closed out — a net gain of 7 holders — while 37 added to existing stakes and 17 trimmed.
The largest buyer was Triasima Portfolio Management, opening a new position worth an estimated $5.17M. The largest seller was EAM Global Investors, cutting an estimated $2.49M.
- 88 institutional investors held Viemed Healthcare (VMD) as of Q1 2023, up from 81 in Q4 2022.
- Funds reported $218M of Viemed Healthcare stock for Q1 2023, up 44% quarter-over-quarter.
- 16 funds opened new Viemed Healthcare positions in Q1 2023 and 9 closed out, a net change of +7 holders.
- The largest Viemed Healthcare buyer in Q1 2023 was Triasima Portfolio Management, an estimated $5.17M added.
- The largest Viemed Healthcare seller in Q1 2023 was EAM Global Investors, an estimated $2.49M sold.
Based on aggregated 13F filings for Q1 2023.